Feds arrest telehealth execs for overprescribing Adderall

Telehealth prescribing and enforcement

  • Some see the arrested company as an example of “good concept, bad execution”: telehealth made ADHD care accessible, but aggressive ad campaigns and loose screening created moral hazard.
  • Others argue the broader pharmaceutical system is already rife with abuse (e.g., opioids), so singling out telehealth is selective.
  • A few note that PayPal’s early success also relied on skirting rules, drawing parallels with “move fast” startup culture.

ADHD diagnosis and overprescription

  • Several commenters think ADHD is overdiagnosed, especially in tech, and predict a future scandal over inflated diagnoses used to access Adderall.
  • Others counter that ADHD lies on a spectrum; many people have meaningful symptoms, so higher diagnosis rates may reflect unmet need rather than pure abuse.

Lived experiences with stimulants

  • Strongly mixed reports:
    • For many with ADHD, stimulants are “life-saving,” enabling basic functioning, planning, and follow-through.
    • Others describe unpleasant effects: somnolence, “zombie” state, emotional blunting, anxiety, or severe crashes.
    • Non-ADHD or recreational use is reported as euphoric, energizing, and motivating, but often with long-term costs and burnout.
  • Multiple users find Ritalin/methylphenidate more moderate and less abusable than Adderall; some argue Adderall should be a last-resort drug.

Adderall shortages and DEA quotas

  • Many ADHD patients describe monthly struggles to fill prescriptions, with shortages exacerbating executive-function challenges.
  • One side blames DEA production caps and rigid controlled-substance rules, calling the shortage largely government-created.
  • Others note manufacturers held substantial raw material during the shortage and highlight a spike in new prescriptions, arguing overprescribing and industry behavior also share blame.

Drug policy, access, and liberty

  • A major subthread debates whether adults should buy Adderall (and even Xanax) freely, like alcohol or nicotine.
  • Pro-legalization voices say the drug war causes massive harm, criminalizes personal choices, and makes quality control impossible.
  • Opponents stress high addiction and mental-health risks, argue many people cannot self-regulate, and support prescription-based “sensible checks.”
  • Historical and international differences (e.g., Adderall bans in some countries) are cited, but their correctness is contested.

Productivity and “smart drugs”

  • Some see stimulants as productivity boosters that governments irrationally restrict.
  • Others cite research and personal experience that they can increase motivation but degrade deep work and decision quality over time.